BANK OF AMERICA CORP /DE/ - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 59 filers reported holding REGULUS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$0
-100.0%
300
-92.5%
0.00%
Q3 2017$5,0004,000
+1318.4%
0.00%
Q2 2017$0
-100.0%
282
-95.9%
0.00%
Q1 2017$11,000
-42.1%
6,874
-19.1%
0.00%
Q4 2016$19,000
+280.0%
8,501
+409.3%
0.00%
Q3 2016$5,000
-68.8%
1,669
-70.0%
0.00%
Q2 2016$16,000
-88.1%
5,557
-71.3%
0.00%
Q1 2016$134,000
-48.7%
19,364
-35.2%
0.00%
Q4 2015$261,000
+12950.0%
29,893
+11668.9%
0.00%
Q3 2015$2,000
-99.6%
254
-99.5%
0.00%
Q2 2015$540,000
+26900.0%
49,274
+54648.9%
0.00%
Q1 2015$2,000
-96.8%
90
-97.7%
0.00%
Q4 2014$63,000
+425.0%
3,951
+198.9%
0.00%
Q1 2014$12,000
-89.6%
1,322
-91.5%
0.00%
Q4 2013$115,000
+5650.0%
15,592
+8912.7%
0.00%
Q3 2013$2,000
-95.8%
173
-96.5%
0.00%
Q2 2013$48,0004,9210.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
RA Capital Management 4,039,823$26,420,0003.79%
Foresite Capital Management II, LLC 1,750,269$11,447,0003.48%
ARGONAUT CAPITAL MANAGEMENT CORP 75,000$491,0001.65%
Abingworth LLP 327,350$2,138,0001.25%
Trellus Management Company, LLC 100,000$654,0000.96%
Cormorant Asset Management, LP 896,522$5,863,0000.94%
DAFNA Capital Management LLC 90,000$589,0000.58%
ORACLE INVESTMENT MANAGEMENT INC 749,064$4,898,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
View complete list of REGULUS THERAPEUTICS INC shareholders